TARGOSAFE 200 INJECTION

Product Description

Product Name: TARGOSAFE 200 INJECTIONComposition: Teicoplanin 200mgCategory: Antibiotic Injection | Glycopeptide Antibiotic | Hospital SuppliesSEO-Optimized Product Description for Trade India & B2B Platforms: TARGOSAFE 200 INJECTION contains Teicoplanin 200mg, a powerful glycopeptide antibiotic used for the treatment of serious gram-positive bacterial infections, including MRSA, bone and joint infections, skin and soft tissue infections, respiratory tract infections, and septicemia. Known for its broad-spectrum activity, long half-life, and excellent tissue penetration, TARGOSAFE is a preferred choice in critical care settings.Manufactured under WHO-GMP certified facilities, TARGOSAFE 200 INJECTION is trusted by hospital pharmacies, ICUs, and healthcare institutions for its clinical reliability and pharmaceutical-grade quality.Key Benefits: Teicoplanin 200mg: Effective against resistant gram-positive infections (including MRSA) Suitable for severe systemic infections and hospital-acquired infections Administered via intravenous (IV) or intramuscular (IM) injection Long-acting formulation enables once-daily dosing Well-tolerated alternative to vancomycin with lower nephrotoxicity risk Ideal for use in ICU, surgical wards, and post-operative infection control Product Specifications: Dosage Form: Injectable Strength: 200mg Teicoplanin per vial Packaging: Glass vial with sterile water for injection Shelf Life: 24 months Storage: Store below 25C in a dry place; protect from light Target Buyers: Pharmaceutical distributors and bulk drug suppliers Hospitals, nursing homes, and critical care units Retail pharmacies and institutional buyers Exporters and government healthcare tenders For Business Inquiries: Contact us for bulk purchase orders, hospital supply contracts, P2P manufacturing, and export partnerships. We ensure regulated quality, competitive pricing, and prompt delivery for domestic and international markets.